Trial intelligence / Profile preview

Duloxetine for Activity-Limiting Osteoarthritis Pain

NCT00609557Phase 4Completed

Sponsor
University of Washington
Start
Sep 2004
Primary completion
Feb 2007
Modality
Small Molecules
01

Overview

Phase 4, single-blind, single-arm trial of duloxetine in osteoarthritis (OA), sponsored by University of Washington. Primary endpoints: Average Pain Intensity on Brief Pain Inventory at 12 weeks and Pain Intensity on Western Ontario McMasters University Osteoarthritis Index at 12 weeks. Started Sep 2004; status: completed.

02

Drugs

duloxetine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00609557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00609557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call